An important objective of the case is to introduce students to the challenges of innovation and strategy in a regulated market environment. Additionally, students will learn the power of multiple forms of intellectual property used strategically along the product life cycle to build and sustain competitive advantage.
Conley, J., Wolcott, R. and Wong, E. (2017), "AstraZeneca, Prilosec, and Nexium: Strategic Challenges in the Launch of a Second-Generation Drug", Kellogg School of Management Cases. https://doi.org/10.1108/case.kellogg.2016.000028Download as .RIS
Kellogg School of Management
Copyright © 2006, The Kellogg School of Management at Northwestern University